218 related articles for article (PubMed ID: 19946339)
1. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway.
Senapati S; Rachagani S; Chaudhary K; Johansson SL; Singh RK; Batra SK
Oncogene; 2010 Mar; 29(9):1293-302. PubMed ID: 19946339
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.
Lacoste J; Aprikian AG; Chevalier S
Mol Cell Endocrinol; 2005 May; 235(1-2):51-61. PubMed ID: 15866427
[TBL] [Abstract][Full Text] [Related]
3. Increased diacylglycerol kinase ζ expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.
Cai K; Mulatz K; Ard R; Nguyen T; Gee SH
BMC Cancer; 2014 Mar; 14():208. PubMed ID: 24646293
[TBL] [Abstract][Full Text] [Related]
4. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.
Mimeault M; Johansson SL; Batra SK
Br J Cancer; 2013 Mar; 108(5):1079-91. PubMed ID: 23449353
[TBL] [Abstract][Full Text] [Related]
5. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
[TBL] [Abstract][Full Text] [Related]
6. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
[TBL] [Abstract][Full Text] [Related]
7. Tpl2 induces castration resistant prostate cancer progression and metastasis.
Lee HW; Cho HJ; Lee SJ; Song HJ; Cho HJ; Park MC; Seol HJ; Lee JI; Kim S; Lee HM; Choi HY; Nam DH; Joo KM
Int J Cancer; 2015 May; 136(9):2065-77. PubMed ID: 25274482
[TBL] [Abstract][Full Text] [Related]
8. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract][Full Text] [Related]
9. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
[TBL] [Abstract][Full Text] [Related]
10. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
11. Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway.
Bokobza SM; Ye L; Kynaston HG; Jiang WG
Oncol Rep; 2010 Dec; 24(6):1653-9. PubMed ID: 21042764
[TBL] [Abstract][Full Text] [Related]
12. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
14. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
Zhang XA; He B; Zhou B; Liu L
J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
[TBL] [Abstract][Full Text] [Related]
15. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination.
Choi HJ; Kim J; Do KH; Park SH; Moon Y
Oncogene; 2013 Oct; 32(41):4960-9. PubMed ID: 23503457
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.
Collins RJ; Morgan LD; Owen S; Ruge F; Jiang WG; Sanders AJ
Int J Cancer; 2018 Nov; 143(10):2537-2550. PubMed ID: 30098000
[TBL] [Abstract][Full Text] [Related]
17. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway.
Jeong YJ; Hwang SK; Magae J; Chang YC
Cell Oncol (Dordr); 2020 Oct; 43(5):793-805. PubMed ID: 32488849
[TBL] [Abstract][Full Text] [Related]
18. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.
Iiizumi M; Bandyopadhyay S; Pai SK; Watabe M; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Furuta E; Liu W; Xing F; Okuda H; Kobayashi A; Watabe K
Cancer Res; 2008 Sep; 68(18):7613-20. PubMed ID: 18794150
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice.
Husaini Y; Qiu MR; Lockwood GP; Luo XW; Shang P; Kuffner T; Tsai VW; Jiang L; Russell PJ; Brown DA; Breit SN
PLoS One; 2012; 7(8):e43833. PubMed ID: 22952779
[TBL] [Abstract][Full Text] [Related]
20. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway.
Sawhney RS; Cookson MM; Omar Y; Hauser J; Brattain MG
J Biol Chem; 2006 Mar; 281(13):8497-510. PubMed ID: 16461767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
